Ethers
This graph shows the total number of publications written about "Ethers" by people in the URMC Research Network by year, and whether "Ethers" was a major or minor topic of these publication.
Below are the most recent publications written about "Ethers" by people in Profiles.
-
Chang Y, Wang Z, Schwan AL, Wang Z, Holm BA, Baatz JE, Notter RH. Surface properties of sulfur- and ether-linked phosphonolipids with and without purified hydrophobic lung surfactant proteins. Chem Phys Lipids. 2005 Oct; 137(1-2):77-93.
-
Halperin SA, Smith B, Clarke K, Treanor J, Mabrouk T, Germain M. Phase I, randomized, controlled trial to study the reactogenicity and immunogenicity of a nasal, inactivated trivalent influenza virus vaccine in healthy adults. Hum Vaccin. 2005 Jan-Feb; 1(1):37-42.
-
Tong Z, Anders MW. Reactive intermediate formation from the 2-(Fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A)-derived cysteine S-conjugate S-[2-(Fluoromethoxy)-1,1,3,3,3-pentafluoropropyl]-L-cysteine in pyridoxal model systems. Chem Res Toxicol. 2002 May; 15(5):623-8.
-
Uttamsingh V, Iyer RA, Baggs RB, Anders MW. Fate and toxicity of 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A)-derived mercapturates in male, Fischer 344 rats. Anesthesiology. 1998 Nov; 89(5):1174-83.
-
Iyer RA, Frink EJ, Ebert TJ, Anders MW. Cysteine conjugate beta-lyase-dependent metabolism of compound A (2-[fluoromethoxy]-1,1,3,3,3-pentafluoro-1-propene) in human subjects anesthetized with sevoflurane and in rats given compound A. Anesthesiology. 1998 Mar; 88(3):611-8.
-
Iyer RA, Baggs RB, Anders MW. Nephrotoxicity of the glutathione and cysteine S-conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1,1,3,3, 3-pentafluoro-1-propene (Compound A) in male Fischer 344 rats. J Pharmacol Exp Ther. 1997 Dec; 283(3):1544-51.
-
Iyer RA, Anders MW. Cysteine conjugate beta-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A). Chem Res Toxicol. 1997 Jul; 10(7):811-9.
-
Iyer RA, Anders MW. Cysteine conjugate beta-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product compound A in human, nonhuman primate, and rat kidney cytosol and mitochondria. Anesthesiology. 1996 Dec; 85(6):1454-61.
-
Lerman J, Davis PJ, Welborn LG, Orr RJ, Rabb M, Carpenter R, Motoyama E, Hannallah R, Haberkern CM. Induction, recovery, and safety characteristics of sevoflurane in children undergoing ambulatory surgery. A comparison with halothane. Anesthesiology. 1996 Jun; 84(6):1332-40.
-
Levine MF, Sarner J, Lerman J, Davis P, Sikich N, Maloney K, Motoyama E, Cook DR. Plasma inorganic fluoride concentrations after sevoflurane anesthesia in children. Anesthesiology. 1996 Feb; 84(2):348-53.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
